Tag Archives: Naloxone

Concentrics Research conducts pivotal studies for novel FDA OTC Naloxone labeling – work cited as unprecedented by FDA Commissioner

Posted January 18th, 2019. Filed under Concentrics News
Tags: FDA, Naloxone, Pivotal Study

Concentrics Research conducts pivotal studies for novel FDA OTC Naloxone labeling – work cited as unprecedented by FDA Commissioner

Concentrics Research Headquarters

9335 Delegates Row Indianapolis, IN 46240

Phone: 800.800.5525 Fax: 317.705.2175

Concentrics Research

Strategy Center

6 Campus Dr.

Parsippany, NJ 07054

Phone: 800.800.5525

Fax: 317.705.2175

Site Links

Contact Us

Web design by BoxCrush®